PRASUGREL TEVA 10 mg, film-coated tablet scored 30 tablets
Active ingredients: Prasugrel hydrobromide, Prasugrel
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PRASUGREL TEVA 10 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- 30 plaquette(s) prédécoupées unitaires OPA : polyamide orienté aluminium polyéthylène+dessicant de 1 comprimé(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Feb 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65361468CIP73014185CIP133400930141854Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PRASUGRELcomprimé | 10 mg · un comprimé | FT |
| BROMHYDRATE DE PRASUGRELcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.